Webinar Replay
The Access Inflection: When the 2025 Playbook Stops Working
Access the Webinar Recording
& Downloadable Signal Briefs
Complete the form to watch the full panel discussion.
Hear directly from market access and managed care experts on the access signals shaping 2026 planning.
Pricing pressure, biosimilar competition, formulary disruption, utilization management, and pull-through barriers are changing how pharmaceutical and biotech teams need to think about access strategy.
In this eMAX Health Systems webinar, a panel of managed care and market access experts shares perspective on the market dynamics that may affect launch planning, contracting, evidence strategy, and patient access in the year ahead.
Why Watch
Access teams are planning in a market that looks different than it did even a year ago. The assumptions that shaped 2025 planning may not be enough for 2026.
This discussion brings forward practical perspective from experts who understand how payer organizations, health plans, and access stakeholders evaluate therapies, manage risk, and respond to changing market conditions.
About eMAX Health Systems
eMAX Health Systems helps pharmaceutical and biotech teams generate stakeholder insight, develop real-world evidence, and inform pricing and access strategy.
Through MAVA®, EMR and claims analytics, payer research, and strategic market access support, eMAX Health Systems helps teams pressure-test assumptions, evaluate access dynamics, and make more confident commercialization decisions.
Designed for pharma and biotech teams focused on access strategy
This session is especially relevant for teams involved in:
-
Market access strategy
-
Pricing and contracting
-
Payer marketing
-
HEOR and evidence planning
-
Launch readiness
-
Reimbursement
-
Pull-through execution
-
Value strategy
-
Oncology
-
Rare disease
-
Immunology
-
Specialty markets
Powered by MAVA® real-time stakeholder insight
MAVA® is eMAX Health’s real-time stakeholder insight platform, helping pharmaceutical and biotech teams pressure-test access strategy with structured input from payer, provider, patient, and channel intermediary stakeholders.
This webinar draws on recent MAVA® insights from payer, provider, and IDN perspectives to explore how access decision-making is evolving in 2026.
